Thrombolytic Therapy for ST-Elevation Myocardial Infarction Presenting to non-Percutaneous Coronary Intervention Centers During the COVID-19 Crisis
Daniel Walters(University of California San Diego), Ehtisham Mahmud(Cardiovascular Institute of the South)
Cited by 11
Related Papers
Catheterization Laboratory Considerations During the Coronavirus (COVID-19) Pandemic
|Journal of the American College of Cardiology|2020|415
Management of Acute Myocardial Infarction During the COVID-19 Pandemic
|Journal of the American College of Cardiology|2020|395
Coronary Optical Coherence Tomography and Cardiac Magnetic Resonance Imaging to Determine Underlying Causes of Myocardial Infarction With Nonobstructive Coronary Arteries in Women
|Circulation|2020|310
Monitoring platelet inhibition after clopidogrel with the VerifyNow-P2Y12® rapid analyzer: The VERIfy Thrombosis risk ASsessment (VERITAS) study
|Thrombosis Research|2006|225
The Hybrid Approach to Chronic Total Occlusion Percutaneous Coronary Intervention
|JACC: Cardiovascular Interventions|2018|213